Cannabis sativa L. Bioactive Compounds and Their Protective Role in Oxidative Stress and Inflammation
The result's identifiers
Result code in IS VaVaI
<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00216224%3A14160%2F22%3A00127119" target="_blank" >RIV/00216224:14160/22:00127119 - isvavai.cz</a>
Result on the web
<a href="https://www.mdpi.com/2076-3921/11/4/660/htm" target="_blank" >https://www.mdpi.com/2076-3921/11/4/660/htm</a>
DOI - Digital Object Identifier
<a href="http://dx.doi.org/10.3390/antiox11040660" target="_blank" >10.3390/antiox11040660</a>
Alternative languages
Result language
angličtina
Original language name
Cannabis sativa L. Bioactive Compounds and Their Protective Role in Oxidative Stress and Inflammation
Original language description
Cannabis (Cannabis sativa L.) plants from the family Cannabidaceae have been used since ancient times, to produce fibers, oil, and for medicinal purposes. Psychoactive delta-9-tetrahydrocannabinol (THC) and nonpsychoactive cannabidiol (CBD) are the main pharmacologically active compounds of Cannabis sativa. These compounds have, for a long time, been under extensive investigation, and their potent antioxidant and inflammatory properties have been reported, although the detailed mechanisms of their actions have not been fully clarified. CB1 receptors are suggested to be responsible for the analgesic effect of THC, while CB2 receptors may account for its immunomodulatory properties. Unlike THC, CBD has a very low affinity for both CB1 and CB2 receptors, and behaves as their negative allosteric modulator. CBD activity, as a CB2 receptor inverse agonist, could be important for CBD anti-inflammatory properties. In this review, we discuss the chemical properties and bioavailability of THC and CBD, their main mechanisms of action, and their role in oxidative stress and inflammation.
Czech name
—
Czech description
—
Classification
Type
J<sub>imp</sub> - Article in a specialist periodical, which is included in the Web of Science database
CEP classification
—
OECD FORD branch
30104 - Pharmacology and pharmacy
Result continuities
Project
—
Continuities
I - Institucionalni podpora na dlouhodoby koncepcni rozvoj vyzkumne organizace
Others
Publication year
2022
Confidentiality
S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů
Data specific for result type
Name of the periodical
Antioxidants
ISSN
2076-3921
e-ISSN
—
Volume of the periodical
11
Issue of the periodical within the volume
4
Country of publishing house
CH - SWITZERLAND
Number of pages
12
Pages from-to
1-12
UT code for WoS article
000786968400001
EID of the result in the Scopus database
2-s2.0-85127383672